Aurobindo Pharma has informed stock exchanges that the completion of its planned captive solar power purchase agreement and acquisition of up to a 26 percent stake in Swarnaakshu Solar Power has been deferred to 31 March, 2026, pending receipt of the required state government approvals.

The company had earlier indicated that the transaction would be completed by 31 December, 2025, but said the timeline has been extended due to the approval process for setting up the captive solar power plant.

Aurobindo Pharma stated that the investment will be completed on or before 31 March, 2026, subject to the necessary regulatory clearances.